Journal of Cancer Research and Therapeutics

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 15  |  Issue : 7  |  Page : 1642--1646

Inhibition of the hypoxia-induced factor-1α and vascular endothelial growth factor expression through ginsenoside Rg3 in human gastric cancer cells


Bingqiang Li1, Guofeng Qu2 
1 Department of General Surgery, Xuzhou Central Hospital, Affiliated to Medical College of Southeast University, Xuzhou, China
2 Department of Breast Surgery, Xuzhou Central Hospital, Affiliated to Medical College of Southeast University, Xuzhou, China

Correspondence Address:
Dr. Guofeng Qu
Department of Breast Surgery, Xuzhou Central Hospital Affiliated to Medical College of Southeast University, Jiefang Road, Xuzhou 221009, Jiangsu Province
China

Objective: The aim of this study is to probe in the inhibitory effects of ginsenoside Rg3 on the expression of hypoxia-induced factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) in human gastric cancer cells. Materials and Methods: Human gastric cancer BGC823 cells were divided into the control group and experiment group, and expression levels of HIF-1α and VEGF were detected by immunocytochemistry and Western blot after cells were cultured under hypoxia for different durations. Results: Under hypoxia, expression of HIF-1α and VEGF in human gastric cancer BGC823 cells showed an increasing trend, and that was remarkably lower in experiment group than in the control group after applying Rg3, which was obvious at 12 and 24 h (P < 0.05). Conclusion: Rg3 can inhibit expression of HIF-1α and VEGF in human gastric cancer cells and may influence abdominal implantation metastasis of gastric cancer through inhibiting its expression.


How to cite this article:
Li B, Qu G. Inhibition of the hypoxia-induced factor-1α and vascular endothelial growth factor expression through ginsenoside Rg3 in human gastric cancer cells.J Can Res Ther 2019;15:1642-1646


How to cite this URL:
Li B, Qu G. Inhibition of the hypoxia-induced factor-1α and vascular endothelial growth factor expression through ginsenoside Rg3 in human gastric cancer cells. J Can Res Ther [serial online] 2019 [cited 2022 May 21 ];15:1642-1646
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2019;volume=15;issue=7;spage=1642;epage=1646;aulast=Li;type=0